President Donald Trump has made a public recommendation against the use of acetaminophen pain relievers, such as Tylenol, particularly by pregnant individuals. This advice stems from a debated connection between this medication and autism. Simultaneously, the President suggested significant modifications to the standard vaccinations administered to infants. All this comes at a time when the White House has pledged a revolution in American health, even as a chorus of voices from the medical and scientific communities expresses widespread apprehension regarding these initiatives.

Acetaminophen has traditionally been considered by medical professionals as one of the safest painkillers for pregnant individuals, particularly given the risks posed by fever and pain to both the mother and developing fetus. However, on Monday, President Trump argued against Tylenol’s benefits, suggesting that pregnant women should avoid its use unless necessary.

The President also proposed major changes to the routine vaccination schedule for infants, specifically questioning the necessity of vaccinating newborns against hepatitis B, an incurable and highly contagious disease. His remarks appear to contradict the established medical consensus that the most effective method of preventing maternal transmission of this potentially life-threatening disease is to vaccinate newborns within the first day of life.

Related: Trump Teases ‘Major’ Autism Announcement Coming Monday

It is important to note that Health and Human Services Secretary Robert F. Kennedy Jr., a key figure in this debate, has expressed skepticism about vaccines and questioned whether approved treatments have contributed to a rise in autism diagnoses. Kennedy pledged earlier this year to release findings concerning the cause of autism, a complex condition generally considered by experts to be predominantly genetic in nature.

It’s clear that the Trump administration’s focus on acetaminophen, Tylenol’s active ingredient, will likely encounter resistance. Major medical groups such as the American College of Obstetricians and Gynecologists have identified acetaminophen as one of the safest options for pain relief and fever reduction during pregnancy.

The evidence suggests a possible connection between acetaminophen exposure and autism, but more recent studies have produced contradictory results. Experts urge that any potential risks posed by the use of such pain relief during pregnancy appear to be lower than the risk of an uncontrolled infection.

The Coalition of Autism Scientists has deemed it ‘highly irresponsible and potentially dangerous’ to claim a direct link between possible exposures and autism, emphasizing that the science is far more nuanced and uncertain.

The debate over medical standards, vaccines, and autism will continue. As citizens, we must stay informed and constantly question, pushing for transparency and truth in all matters of public health.